Sign in to continue:

Sunday, July 26th, 2026

Orion S.A. Q1 2026 Financial Results: Revenue, Net Income, and Key Financial Statements Overview

Orion S.A. Reports Q1 2026 Results: Net Income Drops, Share Repurchases Continue, Dividend Maintained

Key Highlights from Orion S.A. Q1 2026 Earnings Report

  • Net income for Q1 2026 decreased to \$9.1 million, down from \$9.9 million in Q1 2025.
  • Basic and diluted earnings per share (EPS) fell to \$0.16 in the quarter, compared to \$0.18 in Q1 2025.
  • Net sales and cash flow from operations remained under pressure, with net cash provided by operating activities at just \$0.4 million.
  • Share repurchases and dividends continued:
    • Repurchased 233,855 shares of common stock in the quarter.
    • Dividends paid were \$0.02 per share, totaling \$1.2 million.
  • Comprehensive income was a loss of \$4.7 million, driven by unfavorable foreign currency translation and derivative losses.
  • Stockholders’ equity at quarter-end stood at \$379.5 million, down from \$384.6 million at the previous year-end.
  • Shares outstanding as of May 1, 2026: 56,388,649.

Detailed Financial Review

Orion S.A. (NYSE: OEC), a specialty chemicals company, released its quarterly report for the period ended March 31, 2026. The company reported net income of \$9.1 million for the first quarter, representing a decline from \$9.9 million in the same period last year. This translated into basic and diluted earnings per share of \$0.16, compared to \$0.18 a year ago.

The company’s comprehensive income showed a loss of \$4.7 million, a reversal mainly attributed to foreign currency translation adjustments and net losses on derivatives. Specifically, the company reported a \$1.7 million net gain on derivatives for the quarter, but this was offset by larger translation losses.

Cash Flow and Capital Management

Operating cash flow was noticeably weak at \$0.4 million, indicating pressure on cash generation. Orion continued its commitment to shareholder returns through both dividends and share repurchases:

  • Dividends: \$0.02 per share, amounting to \$1.2 million distributed this quarter.
  • Share buybacks: 233,855 shares repurchased, amounting to \$0.8 million in outflow.

Investors should note that net cash used in investing activities was \$29.2 million, largely for capital expenditures and asset acquisitions. This was only partially offset by cash from operations, which may signal ongoing investment in growth or maintenance projects.

Balance Sheet Snapshot

  • Total assets: \$1.91 billion (as of March 31, 2026)
  • Stockholders’ equity: \$379.5 million (down from \$384.6 million at the end of 2025)
  • Retained earnings: \$371.1 million
  • Accumulated other comprehensive loss: (\$72.3 million), reflecting negative impacts from currency and derivatives

Shareholder Structure and Other Notable Points

  • Shares outstanding as of May 1, 2026: 56,388,649
  • Orion S.A. is not classified as an emerging growth or shell company.
  • Company remains listed on the New York Stock Exchange.

Potentially Price-Sensitive Issues

  • Declining Net Income and EPS: The year-over-year drop in profitability may raise concerns about margin pressure, demand, or cost inflation.
  • Low Operating Cash Flow: A sharp drop in cash from operations, especially when paired with continued investment outlays, could lead to liquidity concerns if the trend persists.
  • Comprehensive Loss: The swing to a comprehensive loss due to currency and derivative movements could affect investor sentiment, particularly for those sensitive to non-operating factors.
  • Ongoing Shareholder Returns: The company’s continued share buybacks and steady dividend, despite lower profits, signals management’s confidence but may also draw scrutiny if profits do not rebound.

Conclusion

Overall, Orion S.A. delivered a mixed set of results for the first quarter of 2026. While the company continued its commitment to shareholder returns through dividends and buybacks, both profitability and cash flow have weakened compared to the prior year. The comprehensive loss and reduced stockholders’ equity are additional red flags for investors to monitor. Shareholders should watch for management’s commentary on future quarters, especially regarding operational improvements, cost controls, and foreign exchange risk management.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with financial professionals before making investment decisions. The financial data presented is based on the company’s unaudited quarterly report for Q1 2026 and may be subject to revision.

View Orion S.A. Historical chart here



Silence Therapeutics plc 2025 Annual Report: siRNA Therapeutics Pipeline, Business Overview, and Regulatory Insights

Silence Therapeutics plc 2025 Annual Report: Key Points for ...

Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook

Clene Inc. 2025 Annual Report: Key Highlights for Investors ...